CXCL12/CXCR4 promotes motility and proliferation of glioma cells

Cancer Biology and Therapy

Volumn 9, Issue 1, 2010, Pages

  Do Carmo, Anália ^a,c,d   Patricio, I ^a   Cruz, M T ^a,b   Carvalheiro, H ^a   Oliveira, C R ^a,c   Lopes, M C ^a,b,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d University School Vasco da Gama   (Portugal)

Author keywords

Apoptosis; Brain tumor; Chemotaxis; CXCL12; CXCR4; Glioblastoma; Proliferation

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; F ACTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLERIXAFOR; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1;

ACTIN FILAMENT; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BRAIN TUMOR; CELL MOTION; GENETICS; GLIOBLASTOMA; GLIOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; CHEMOTAXIS; GLIOBLASTOMA; GLIOMA; HUMANS; RECEPTORS, CXCR4;

EID: 75749086811     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Pédeboscq S, Azou B, Liguoro D, Pometan J, Cambar. Interindividual differences in anticancer drug cytotoxicity in primary glioblastoma cells. Exp Toxicol Pathol 2007; 58:247-53.
2. Wen P, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359:492-507.
3. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, et al. Malignant astrocytic glioma: genetics, biology and paths to treatment. Genes Dev 2007; 21:2683-710.
4. Stevenson CB, Ehtesham M, McMillan KM, Valadez JG, Edgeworth ML, Price RR, et al. CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities. Neurosur 2008; 63:560-70.
5. Burge J, Peled A. CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 2009; 23:43-52.
6. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, et al. Stromal Cell-derived Factor-1α stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003; 63:1969-74.
7. Zhou Y, Larsen P, Hao C, Yong V. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 2002; 277:49481-7.
8. Fulton A. The Chemokine Receptors CXCR4 and CXCR3 in cancer. Cur Oncol Rep 2009; 11:125-31.
9. Peng SB, Peek V, Zhai Y, Paul DC, Lou Q, Xia X, et al. Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells. Mol Cancer Res 2005; 3:227-36.
10. Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 2006; 20:1915-24.
11. Busillo JM, Benovic JL. Regulation of CXCR4 signaling. BBA 2007; 1768:952-63.
12. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. PNAS 2003; 100:13513-8.
13. Ehtesham M, Winston JA, Kabos P, Thompson RC. CXCR4 expression mediates glioma cell invasiveness. Oncogene 2006; 25:2801-6.
14. Redjal N, Chan JA, Segal RA, Kung AL. CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res 2006; 12:6765-71.
15. Kryczek I, Wei S, Keller E, Liu R, Zou W. Stromaderived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 2007; 292:987-95.
16. Rempel SA, Dudas S, Ge S, Gutierrez JA. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 2000; 6:102-11.
17. Burger J, Kipps T. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006; 107:1761-7.
18. Neves B, Cruz M, Francisco V, Gonçalo M, Figueiredo A, Duarte C, et al. Differential modulation of CXCR4 and CD40 protein levels by skin sensitizers and irritants in the FSDC cell line. Toxicol Lett 2008; 177:74-82.
19. Liang C Park A, Guan J. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007; 2:329-33.
20. Ziegler DS, Kung AL, Kieran MW. Anti-apoptosis mechanisms in malignant gliomas. J Clin Oncol 2008; 20:493-500.
21. Bian XW, Yang SX, Chen JH, Ping YF, Zhou XD, Wang QL, et al. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival. Neurosurg 2007; 61:570-9.
22. Rosenkilde M, Gerlach L, Jakobsen J, Skerlj R, Bridger G, Schwartz T. Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor. J Biol Chem 2004; 279:3033-41.
23. Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang XP, DeCarvalho AC, et al. SDF-1 and CXCR4 are upregulated by VEGF and contribute to glioma cell invasion. Cancer Lett 2006; 236:39-45.
24. Fricker SP, Anastassov V, Cox J, Darkes MC, Grujic O, Idzan SR, et al. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Biochem Pharmacol 2006; 72:588-96.
25. De Clercq E. The bicyclam AMD3100 story. Nat Rev Drug Discov 2003; 2:581-7.
26. Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, et al. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 2006; 66:2181-7.
27. Ohira S, Sasaki M, Harada K, Sato Y, Zen Y, Isse K, et al. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factoralpha and stromal-derived factor-1 released in stroma. Am J Pathol 2006; 168:1155-68.
28. Marchesi F, Monti P, Leone BE, Zerbi A, Vecchi A, Piemonti L, et al. Increased survival, proliferation and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 2004; 64:8420-7.
29. Cabioglu N, Summy J, Miller C, Parikh NU, Sahin AA, Tuzlali S, et al. CXCL12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res 2005; 65:6493-7.
30. Hambardzumyan D, Squatrito M, Carbajal E, Holland EC. Glioma formation, cancer stem cells and akt signaling. Stem Cell Rev 2008; 4:203-10.
31. Ren Liu R, Bo Tian B, Gearing M, Hunter S, Ye K, Mao Y. Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. PNAS 2008; 27:7570-5.
32. Yang S, Chen J, Jiang X, Wang Q, Chen Z, Zhao W, et al. Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor. Biochem Biophys Res Com 2005; 335:523-8.
33. Brandimarti R, Khan M, Fatatis A, Meucci O. Regulation of cell cycle proteins by chemokine receptors: A novel pathway in human immunodeficiency virus neuropathogenesis? J NeuroVirol 2004; 10:1-5.
34. Ndozangue-Touriguine O, Hamelin J, Bréard J. Cytoskeleton and apoptosis. Biochem Pharmacol 2008; 76:11-8.